Skip to main content
The George Institute for Global HealthThe George Institute for Global Health
Covid-19 Covid 19 Covid 19

Social links UK

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
The George Institute for Global Health
  • About us
    • Our Mission And Values
    • Our Strategy
    • Our History
    • How Our Research Is Different
    • Our People
    • Board Of Directors
    • Global Advisory Committee (ACRIS)
    • Our Affiliates And Collaborators
    • George Health
    • Annual Reports
    • Financial Statements
  • Our Work
    • Our Priorities
    • Better Treatments
    • Better Care
    • Healthier Societies
    • Ongoing Projects
    • Archived Projects
    • Publications
  • News & Events
    • Media Releases
    • News Stories
    • Media Coverage
    • Media Enquiries
    • Events
    • Past Events
    • Blogs / Profile Stories
    • E-Newsletters
    • Videos
    • Podcasts
  • Our Impact
    • Impacting Policy And Practice
    • Reports And Recommendations
    • Case Studies And Examples
    • Advocacy And Thought Leadership
    • Disruptive Social Entrepreneurship
  • Careers & studies
    • The George Experience
    • Research Training Programs
    • Current Job Opportunities
  • Contact Us
  • Get involved
    • Giving Opportunities
    • Building Back Better After COVID-19: The Research Agenda
    • Reclaiming Comprehensive Public Health: A Call to Action
    • Universal Health Coverage: A Call To Action
    • The NCD Lab on Women and Girls
  1. Home
  2. Publications

POS-254 CLINICAL AND SAFETY OUTCOMES WITH APIXABAN VERSUS WARFARIN BY EGFR IN ADULTS WITH ATRIAL FIBRILLATION

Authors
M Jun
Type of Publication
Journal Article
Year of Publication
2022
Journal
Kidney International Reports
Language
Eng
Volume
7
Number of Pages
S111 - S112
Links to full text
  • Google Scholar
  • BibTeX
  • EndNote X3 XML
  • EndNote 7 XML
  • Endnote tagged
  • Marc
  • RIS
Search Publications

Latest Publications

  • Commentary on the 2020 update of the KDOQI clinical practice guideline for nutrition in chronic kidney disease

    Nephrology

    2022

  • School staff perceptions of the nature and consequences of students’ use of e-cigarettes

    Australian and New Zealand Journal of Public Health

    2022

  • A comparative policy analysis of the adoption and implementation of sugar-sweetened beverage taxes (2016-19) in 16 countries

    HEALTH POLICY AND PLANNING

    2022

  • Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.

    JAMA

    2022

View all
  • About us
  • Our Work
  • News & Events
  • Our Impact
  • Careers & studies
  • Get involved
  • Thought leadership
  • Contact us

The George Institute for Global Health

Central Working - Fourth Floor
Translation and Innovation Hub
Imperial College London
84 Wood Lane, London W12 0BZ
United Kingdom
info@georgeinstitute.org.uk

The George Institute country sites:

  • The George Institute country sites:
  • Australia
  • China
  • India
  • UK
  • In collaboration with Imperial College London

Social links UK

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe to our E-newsletter

Copyright © 2022 The George Institute

Footer Links

  • Disclaimer
  • Privacy policy
  • Data sharing policy
  • Whistleblower policy
  • Modern slavery statement
  • Research code policy
  • PHS awards financial COI policy
  • Sitemap
Please register to download the report
×

Thank you for your interest in the FoodSwitch – State of the Food Supply Report 2021

You should receive an email with a link to download the report.

If you don't see it in your inbox, please check you spam folder in case it has been held there.